These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10586096)

  • 21. Increased in vivo frequency of IA-2 peptide-reactive IFNgamma+/IL-4- T cells in type 1 diabetic subjects.
    Herzog BA; Ott PA; Dittrich MT; Quast S; Karulin AY; Kalbacher H; Karges W; Tary-Lehmann M; Lehmann PV; Boehm BO; Durinovic-Belló I
    J Autoimmun; 2004 Aug; 23(1):45-54. PubMed ID: 15236752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.
    Martinuzzi E; Novelli G; Scotto M; Blancou P; Bach JM; Chaillous L; Bruno G; Chatenoud L; van Endert P; Mallone R
    Diabetes; 2008 May; 57(5):1312-20. PubMed ID: 18305140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poor in vitro induction of FOXP3 and ICOS in type 1 cytokine environment activated T-cells from children with type 1 diabetes.
    Honkanen J; Skarsvik S; Knip M; Vaarala O
    Diabetes Metab Res Rev; 2008; 24(8):635-41. PubMed ID: 18973208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic cell-based assays, but not mannosylation of antigen, improves detection of T-cell responses to proinsulin in type 1 diabetes.
    Narendran P; Elsegood K; Leech NJ; Macindoe WM; Boons GJ; Dayan CM
    Immunology; 2004 Apr; 111(4):422-9. PubMed ID: 15056379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Islet-cell antigen-reactive T cells show different expansion rates and Th1/Th2 differentiation in type 1 diabetic patients and healthy controls.
    Ott PA; Herzog BA; Quast S; Hofstetter HH; Boehm BO; Tary-Lehmann M; Durinovic-Bello I; Berner BR; Lehmann PV
    Clin Immunol; 2005 Apr; 115(1):102-14. PubMed ID: 15870028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of clonal deletion vs. anergy of self-reactive CD4 T-cells for the prevention and reversal of autoimmune diabetes.
    Preda-Pais A; Stan AC; Casares S; Bona C; Brumeanu TD
    J Autoimmun; 2005 Aug; 25(1):21-32. PubMed ID: 16005609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health.
    Arif S; Tree TI; Astill TP; Tremble JM; Bishop AJ; Dayan CM; Roep BO; Peakman M
    J Clin Invest; 2004 Feb; 113(3):451-63. PubMed ID: 14755342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro secretion of interleukin 2 and expression of IL-2 receptor in peripheral blood lymphocytes in high risk of insulin-dependent diabetes mellitus subjects.
    Kretowski A; Myśliwiec J; Szelachowska M; Brzozowski C; Pietruczuk M; Kinalska I
    Arch Immunol Ther Exp (Warsz); 1999; 47(1):45-9. PubMed ID: 11729828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection of GAD65 reactive T cells in some Chinese subjects initially diagnosed as with idiopathic type 1 diabetes].
    Zhang Y; Zhou ZG; Yang L; Zhou HF; Lin J; Sun Y; Huang G
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(16):1102-5. PubMed ID: 17672990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defective autologous mixed leukocyte reaction in newly diagnosed type 1 diabetes mellitus.
    Räsänen L; Hyöty H; Lehto M; Kallioniemi OP; Antonen J; Huupponen T; Karjalainen J; Leinikki P
    Clin Exp Immunol; 1988 Mar; 71(3):470-4. PubMed ID: 2968203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recognition of heat shock protein 60 epitopes in children with type 1 diabetes.
    Verrijn Stuart AA; de Jager W; Klein MR; Teklenburg G; Nuboer R; Hoorweg JJ; de Vroede MA; de Kruijff I; Fick M; Schroor EJ; van der Vlist GJ; Meerding J; Kamphuis S; Prakken BJ
    Diabetes Metab Res Rev; 2012 Sep; 28(6):527-34. PubMed ID: 22492505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-mediated immunity in the aetiopathogenesis of insulin-dependent (type I) diabetes mellitus.
    Pozzilli P; Zuccarini O; Sensi M; Spencer KM; Bottazzo G
    Biomed Biochim Acta; 1984; 43(5):621-5. PubMed ID: 6236800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic aspects of type I diabetes.
    Dobersen MJ; Chase HP
    Pediatrician; 1983-1985; 12(4):173-8. PubMed ID: 6400449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A proinsulin 74-90-derived protease-resistant, altered peptide ligand increases TGF-beta 1 secretion in PBMC from patients with type 1 diabetes mellitus.
    van Aalst D; Kalbacher H; Palesch D; Zou F; Spyrantis A; Rosinger S; Boehm BO; Burster T
    J Leukoc Biol; 2010 May; 87(5):943-8. PubMed ID: 20110445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes.
    Monti P; Scirpoli M; Rigamonti A; Mayr A; Jaeger A; Bonfanti R; Chiumello G; Ziegler AG; Bonifacio E
    J Immunol; 2007 Nov; 179(9):5785-92. PubMed ID: 17947651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutting edge: type 1 diabetes occurs despite robust anergy among endogenous insulin-specific CD4 T cells in NOD mice.
    Pauken KE; Linehan JL; Spanier JA; Sahli NL; Kalekar LA; Binstadt BA; Moon JJ; Mueller DL; Jenkins MK; Fife BT
    J Immunol; 2013 Nov; 191(10):4913-7. PubMed ID: 24123682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Destabilization of peptide:MHC interaction induces IL-2 resistant anergy in diabetogenic T cells.
    Edwards LJ; Evavold BD
    J Autoimmun; 2013 Aug; 44():82-90. PubMed ID: 23895744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen-specific dose-dependent system for the study of an inheritable and reversible phenotype in mouse CD4+ T cells.
    Firpo EJ; Kong RK; Zhou Q; Rudensky AY; Roberts JM; Franza BR
    Immunology; 2002 Dec; 107(4):480-8. PubMed ID: 12460193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cells and autoantibodies to human HSP70 in type 1 diabetes in children.
    Abulafia-Lapid R; Gillis D; Yosef O; Atlan H; Cohen IR
    J Autoimmun; 2003 Jun; 20(4):313-21. PubMed ID: 12791317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of T-cell anergy and suppression in susceptibility to IDDM.
    Bergerot I; Arreaza G; Cameron M; Chou H; Delovitch TL
    Res Immunol; 1997 Jun; 148(5):348-58. PubMed ID: 9352600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.